Board drops fund raising plan; Q2 net profit jumps to Rs 5.6 cr
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board decided not to proceed with the fund raising proposal as management already arranged funding through banking channels. May revisit later if needed. Q2 FY26 standalone net profit was Rs 5.60 cr vs a loss of Rs 11.16 cr YoY, on revenue of Rs 157.21 cr. H1 FY26 net profit stood at Rs 13.17 cr vs a loss of Rs 11.60 cr, with revenue up 10 percent to Rs 361.61 cr. Also added 10 officers to senior management under organisational realignment.
No immediate dilution risk from equity issue; Q2 profit turnaround is positive. Funding now sourced via banks.